References
- ABELOFF, M. D., 1995, Vinorelbine (Navelbine) in the treatment of breast cancer: a summary. Seminars in Oncology, 22 (suppl. 4), 1–4, discussion 41–44.
- CROS, S., WRIGHT, M., MORIMOTO M, LATASTE, H., COUZIN1ER, J. P. and KRIKORIAN, A., 1989, Experimental antitumor activity of Navelbine. Seminars in Oncology, 16 (suppl. 4), 15–20.
- GASKELL L, S. J.1992, Hybrid tandem mass spectrometer in biological research. Biological Mass Spectrometry, 21, 413–419.
- GOA, K. L. and FAULDS, D., 1994, Vinorelbine—a review of its pharmacological properties and clinical use in cancer chemotherapy. Drugs and Aging, 5, 200–234.
- JEHL, F., Quour, E., LEVEQUE, D., PAULI, G., BREILLOUT, F., KRIKORIAN, A. and MONTEIL, H., 1991, Pharrnacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography. Cancer Research, 51, 2073–2076.
- JOS, S. F. and BURRIS, H. A., 1996, Vinorelbine: a new antineoplastic drug for the treatment of non-small-cell lung cancer. Annals Pharmacotherapy,, 30, 501–506.
- KOBAYASHI, S., SAKAI, T., DALRYMPLE, P. D., WOOD, S. G. and CHASSEAUD, L. F., 1993. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Arzneimittel-Forschung /Drug Research, 43, 1367–1377.
- LEVEQUE, D., JEHL, F., Quorx, E. and MONTEIL, H., 1993, Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography. Xeno-biotica, 23, 1325–1333.
- MANGENEY, P., ADRIAMIALISOA, R. Z., LALLEMAND, J. Y., LAMGOLOIS, N., LAMGOLOIS Y. and POTIER P., 1979a, 5'-Noranhidrovinblastine. Prototype of a new class of vinblastine derivatives. Tetrahedron, 35, 2175–2179.
- MANGENEY, P., ADRIAMIALISOA, R. Z., LALLEMAND, J. Y., LAMGOLOIS, N., LAMGOLOIS, Y. and POTIER P., 1979b, A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine type alkaloids. Journal of Organic Chemistry, 44, 3765–3768.
- MEYERS, M. B., SCOTTO, K. W. and SIROTNAK, F. M., 1991, P-glycoprotein content and mediation of vincristine efflux: correlation with the level of differentiation in luminal epithelium of mouse small intestine. Cancer Communications Survey, 3, 159–165.
- RAHMANI, R. and Znou, X. J., 1993, Pharmacokinetics and metabolism of vinca alkaloids. Cancer Survey, 17, 269–281.
- SARIASLANI, F. S., DUFFEL, M. W. and ROSAZZA, J. P., 1985, Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension. Journal of Medical Chemistry, 28, 629–633.
- TOSO, C. and LINDLEY, C., 1995, Vinorelbine: a novel vinca alkaloid. American Journal of Health Systems and Pharmacology, 52, 1287–1304.
- VAN TELLINGEN, O., KUUPERS, A. V., BEIJNEN, J. H., NOOIJEN, W. J. and BULT, A., 1993, Plasma pharrnacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography. Investigational New Drugs, 11, 141–150.
- WARGIN, W. A. and LUCAS, V. S., 1994, The clinical pharmacokinetics of vinorelbine (navelbine). Seminars in Oncology, 21 (suppl. 10), 21–27.
- ZUOU, X. J., PLACID', M. and RAHMAN', R., 1994, One-electron oxidation of vindoline and 16–0 acetylvindoline catalysed by peroxidase. Anticancer Research, 14, 1017–1022.